In this experiment, only the MD and HD groups showed significant improvement in inflammation, and both body weight and the level of CRP in the LD group were not significantly different from those in the HF group, indicating that PEX-168 at medium doses and above significantly reduces body weight in simple obese mice, thereby improving the inflammatory reaction and reducing cardiovascular risk. The gene discussed is CRP; the disease is hydrops fetalis.